Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo Nordisk on LinkedIn:
”New data from Novo Nordisk in hemophilia A, published in NEJM Group, reinforces the strategic direction of the portfolio.
The results highlight the potential of an investigational prophylactic therapy to reduce bleeding episodes across patient segments, including those with inhibitors – while enabling greater treatment individualization, a key driver of next-generation care models.
This builds on well-established progress in hemophilia, where advances in prophylaxis have materially improved quality of life and extended life expectancy toward that of the general population.”
Novo Nordisk shared on LinkedIn about a recent article by Maria Elisa Mancuso et al, published in NEJM, adding:
”Results from Novo Nordisk’s hemophilia research published in NEJM Group highlights the potential of an investigational preventive bleed treatment option to help people living with hemophilia A, with or without inhibitors.
Learn more in the press release.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg for the FRONTIER2 Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime